These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 2470839
1. Determination of a glucose-containing tetrasaccharide in urine of patients with acute pancreatitis. Kumlien J, Andrén-Sandberg A, Zopf D, Lundblad A. Int J Pancreatol; 1989 Mar; 4(2):139-47. PubMed ID: 2470839 [Abstract] [Full Text] [Related]
2. Urinary excretion of a glucose-containing tetrasaccharide. A parameter for increased degradation of glycogen. Kumlien J, Chester MA, Lindberg BS, Pizzo P, Zopf D, Lundblad A. Clin Chim Acta; 1988 Aug 15; 176(1):39-48. PubMed ID: 3168292 [Abstract] [Full Text] [Related]
3. Studies on the metabolic origin of a glucose-containing tetrasaccharide in human urine. Ugorski M, Seder A, Lundblad A, Zopf D. J Exp Pathol; 1983 Aug 15; 1(1):27-38. PubMed ID: 6400638 [Abstract] [Full Text] [Related]
4. [Utility of amylase serum and urine activity in acute biliary pancreatitis treated with biliary sphincterotomy]. Wojtuń S, Gil J. Pol Merkur Lekarski; 2007 May 15; 22(131):381-4. PubMed ID: 17679374 [Abstract] [Full Text] [Related]
5. Urine trypsinogen-2 as marker of acute pancreatitis. Hedström J, Sainio V, Kemppainen E, Puolakkainen P, Haapiainen R, Kivilaakso E, Schauman KO, Stenman UH. Clin Chem; 1996 May 15; 42(5):685-90. PubMed ID: 8653892 [Abstract] [Full Text] [Related]
6. Structural and immunochemical analysis of three alpha-limit dextrin oligosaccharides. Kumlien J, Grönberg G, Nilsson B, Månsson O, Zopf D, Lundblad A. Arch Biochem Biophys; 1989 Mar 15; 269(2):678-89. PubMed ID: 2919890 [Abstract] [Full Text] [Related]
7. Comparative evaluation of the diagnosis of acute pancreatitis based on serum and urine enzyme assays. Gwozdz GP, Steinberg WM, Werner M, Henry JP, Pauley C. Clin Chim Acta; 1990 Mar 15; 187(3):243-54. PubMed ID: 2323064 [Abstract] [Full Text] [Related]
8. Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease. An Y, Young SP, Kishnani PS, Millington DS, Amalfitano A, Corz D, Chen YT. Mol Genet Metab; 2005 Aug 15; 85(4):247-54. PubMed ID: 15886040 [Abstract] [Full Text] [Related]
9. P amylase is always greater than S in spot urine of normal subjects. Diagnostic implications. Bank S, Abrol RP, Greenberg R, Blumstein M, Kranz V. Int J Pancreatol; 1992 Jun 15; 11(3):191-4. PubMed ID: 1381408 [Abstract] [Full Text] [Related]
14. [Changes of amylase activity in human serum and urine due to some diseases]. Trpinac P, Vlajnić R, Pavlović V, Mihailović V, Baretić M. Med Pregl; 1968 Mar 15; 21(9):347-9. PubMed ID: 5195811 [No Abstract] [Full Text] [Related]
15. Determination of a glucose-containing tetrasaccharide in urine by radioimmunoassay. Zopf DA, Levinson RE, Lundblad A. J Immunol Methods; 1982 Mar 15; 48(1):109-19. PubMed ID: 7057040 [Abstract] [Full Text] [Related]
20. Diurnal variability of glucose tetrasaccharide (Glc4) excretion in patients with glycogen storage disease type III. Young SP, Khan A, Stefanescu E, Seifts AM, Hijazi G, Austin S, Kishnani PS. JIMD Rep; 2021 Mar 15; 58(1):37-43. PubMed ID: 33728245 [Abstract] [Full Text] [Related] Page: [Next] [New Search]